- Home
- COGT vs TWFG Comparison
COGT vs TWFG Comparison
Compare COGT & TWFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- TWFG
- Stock Information
- Founded
- COGT 2014
- TWFG 2001
- Country
- COGT United States
- TWFG United States
- Employees
- COGT N/A
- TWFG N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- TWFG
- Sector
- COGT Health Care
- TWFG
- Exchange
- COGT Nasdaq
- TWFG NYSE
- Market Cap
- COGT 545.3M
- TWFG 470.4M
- IPO Year
- COGT 2018
- TWFG 2024
- Fundamental
- Price
- COGT $4.81
- TWFG $32.24
- Analyst Decision
- COGT Buy
- TWFG Buy
- Analyst Count
- COGT 7
- TWFG 8
- Target Price
- COGT $14.00
- TWFG $33.00
- AVG Volume (30 Days)
- COGT 1.3M
- TWFG 97.1K
- Earning Date
- COGT 05-06-2025
- TWFG 05-13-2025
- Dividend Yield
- COGT N/A
- TWFG N/A
- EPS Growth
- COGT N/A
- TWFG N/A
- EPS
- COGT N/A
- TWFG 0.19
- Revenue
- COGT N/A
- TWFG $203,760,000.00
- Revenue This Year
- COGT N/A
- TWFG $22.41
- Revenue Next Year
- COGT N/A
- TWFG $20.43
- P/E Ratio
- COGT N/A
- TWFG $175.10
- Revenue Growth
- COGT N/A
- TWFG 18.44
- 52 Week Low
- COGT $3.72
- TWFG $21.31
- 52 Week High
- COGT $12.61
- TWFG $36.50
- Technical
- Relative Strength Index (RSI)
- COGT 44.64
- TWFG N/A
- Support Level
- COGT $4.55
- TWFG N/A
- Resistance Level
- COGT $5.89
- TWFG N/A
- Average True Range (ATR)
- COGT 0.38
- TWFG 0.00
- MACD
- COGT 0.09
- TWFG 0.00
- Stochastic Oscillator
- COGT 34.55
- TWFG 0.00
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About TWFG TWFG INC
TWFG Inc is a independent distribution platform for personal and commercial insurance in the United States. It offers all lines of insurance, multiple distribution contract options, M&A services, proprietary virtual assistants, proprietary technology, proprietary premium financing, unlimited continuing education, recognition programs, co-op funding, marketing support and overall lower costs to operate.